PDFWAC 246-945-457
Remote dispensing sites for opioid use disorder medications.
A pharmacy may extend its license to register a remote dispensing site where technology is used to dispense medications used for treatment of opioid use disorder or its symptoms. A pharmacy holding this registration is the supplying pharmacy and must comply with subsections (1) through (5) of this section and all applicable regulations in Title 21 of the Code of Federal Regulations.
(1) The supplying pharmacy must separately register each remote dispensing site with the commission by completing and returning an application form supplied by the commission and pay applicable fees established by the secretary.
(2) Medications stored in registered remote dispensing sites shall remain under the control of, and be routinely monitored by, the supplying pharmacy.
(3) The supplying pharmacy shall develop and implement policies and procedures to:
(a) Prevent and detect unauthorized access to the registered remote dispensing site;
(b) Document medications used, returned, and wasted from the registered remote dispensing site;
(c) Require the supplying pharmacy to perform a perpetual inventory of medications stored at the registered remote dispensing site; and
(d) Ensure that only the supplying pharmacy is stocking medications stored at a registered remote dispensing site.
(4) Access and retrieval of medications from the registered remote dispensing site, other than by the supplying pharmacy, must be:
(a) Pursuant to a valid prescription or chart order; and
(b) Limited to health care professionals licensed under the chapters specified in RCW 18.130.040 who are acting within their scope of practice, and nursing students as provided in WAC 246-945-450.
(5) The supplying pharmacy shall ensure the registered remote dispensing site is appropriately equipped to secure and protect medications from diversion or tampering.
[Statutory Authority: RCW 18.64.005 and 2020 c 244. WSR 24-01-098, ยง 246-945-457, filed 12/18/23, effective 1/18/24.]